What one share of Journey Medical holds
We are a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions.
Journey Medical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.55 |
|---|---|
| Profit | −$0.23 |
| Cash and investments | $0.93 |
| Debt | $0.93 |
| Book value | $1.17 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $4.11 | $0.49 | — | — | — | — |
| 2021 | $6.20 | −$4.32 | — | — | — | $3.72 |
| 2022 | $4.20 | −$1.69 | $1.14 | −$1.91 | — | $0.97 |
| 2023 | $4.34 | −$0.21 | $0.27 | $0.01 | — | $1.12 |
| 2024 | $2.75 | −$0.72 | $0.73 | −$1.18 | — | $0.98 |
| 2025 | $2.52 | −$0.47 | — | — | — | $1.30 |
Common questions about Journey Medical
How much does one share of Journey Medical earn?
Over the last 12 months, Journey Medical lost $0.23 for each share on $2.55 of sales.
Does Journey Medical pay a dividend?
Journey Medical didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Journey Medical’s book value per share?
Journey Medical’s book value is $1.17 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Journey Medical have?
Each share of Journey Medical has $0.93 of cash and investments and $0.93 of debt, as of June 30, 2026.
Has Journey Medical bought back shares?
Journey Medical’s share count rose about 126% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.